Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-26-237882
Filing Date
2026-05-26
Accepted
2026-05-26 07:33:06
Documents
3
Period of Report
2026-05-26

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_5.26.26_data_webinar.htm 6-K 33016
2 EX-99.1 vrax-ex99_1.htm EX-99.1 22862
3 GRAPHIC img90071954_0.jpg GRAPHIC 19912
  Complete submission text file 0001193125-26-237882.txt   84655
Mailing Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH
Business Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41440 | Film No.: 261015943
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)